Dimra 20 tablets

Tradename:

Dimra

Dimra

Compound:

Each tablet contains:

Diclofenac potassium 50 mg

Metocarbamol 500 mg

Auxiliary components:

Starch, croscarmellose, povidone K30, magnesium stearate, talc.

Properties:

Diclofenac Potassium:

non-steroidal anti-inflammatory drug (NSAID). Dimra tablets contain the potassium salt of diclofenac, an ncn-steroldate compound with pronounced and clinically manifested analgesic, anti-inflammatory and antipyretic properties. Diclofenac is a potent inhibitor of prostaglandin biosynthesis and a modulator of the release and absorption of arachidonic acid. Diclofenac Potassium has a rapid onset of action and is therefore suitable for the treatment of acute attacks of pain and inflammation.

Methocarbamol 500 is used as a short-term adjunct to the symptomatic treatment of acute musculoskeletal disorders associated with painful muscle spasms.

Indications:

For the relief of pain in musculoskeletal disorders associated with muscle spasm and injury, such as:

– stretching

– backache

– tense neck muscles

Dosage and administration:

Unless otherwise directed by a physician, 1 to 3 tablets daily.

– For oral administration.

– Preferably taken with or after meals.

– Tablets should be swallowed whole with liquid.

Contraindications:

Hypersensitivity to diclofenac, methocarbamol or any of the excipients. Due to the presence of Dclofenac Potassium:

• Active or recurrent bleeding from a history of peptic ulcer (two or more separate episodes of proven ulcer or bleeding).

• NSAIDs are contraindicated in patients who have previously experienced hypersensitivity reactions (eg, asthma, rhinitis, angioedema, or urticaria) in response to ibuprofen, aspirin, or other non-steroidal anti-inflammatory drugs.

• Severe heart failure, liver and kidney failure.

• This medicine contains soy. If you are allergic to peanuts or soy, do not take this medicine.

Precautionary measures:

Increased risk of serious gastrointestinal adverse events including inflammation, bleeding, ulceration and perforation of the stomach or intestines, which can be fatal, these events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk of serious gastrointestinal disease.

Undesirable effects can be minimized by using the lowest effective dose for the shortest time necessary to control symptoms.

The use of diclofenac potassium with concomitant NSAIDs, including selective cyclooxygenase-2 inhibitors, should be avoided.

Side effects:

From the nervous system: often – headache, dizziness; rarely – drowsiness;

On the part of the organ of hearing and labyrinth disorders: often – vertigo; very rarely – hearing impairment, tinnitus.

From the digestive system: often – dry mouth, abdominal pain, nausea, vomiting, belching, heartburn, diarrhea, dyspepsia, flatulence, anorexia, increased activity of hepatic transferases in the blood serum; infrequently – loss of appetite, anorexia; rarely – gastrointestinal bleeding, vomiting of blood, melena, diarrhea mixed with blood, stomach and intestinal ulcers (with or without bleeding or perforation), gastritis, hepatitis, jaundice.

Storage method:

Store at a temperature not exceeding 30 degrees.

Package:

The cardboard box contains 2 blisters of 10 tablets.